Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism.

Zhang, Ling-Yun

Clinical efficacy of low dose recombinant tissue-type plasminogen activator for the treatment of acute intermediate-risk pulmonary embolism. [electronic resource] - Saudi medical journal Nov 2018 - 1090-1095 p. digital

Publication Type: Comparative Study; Journal Article; Randomized Controlled Trial

1658-3175

10.15537/smj.2018.11.22717 doi


Acute Disease
Aged
Anticoagulants--therapeutic use
Arterial Pressure--drug effects
Female
Fibrinolytic Agents--therapeutic use
Heparin, Low-Molecular-Weight--therapeutic use
Humans
Male
Middle Aged
Pulmonary Artery
Pulmonary Embolism--drug therapy
Recombinant Proteins--therapeutic use
Systole
Tissue Plasminogen Activator--therapeutic use